Skip to content
Search

Latest Stories

RPS England director Ravi Sharma resigns to take up top job at Luton & Dunstable University Hospital

The Royal Pharmaceutical Society (RPS) England director, Ravi Sharma, has resigned after four years on the job.

He will be leaving the RPS in October to join Luton and Dunstable University Hospital, part of the Bedfordshire Hospitals NHS Foundation Trust group, as head of pharmacy.


RPS will be commencing the recruitment of a new director for England shortly and in the interim Ravi will be working with Paul Bennett, the RPS CEO, to help in delivery of key objectives and in the appointment of his successor.

Paul commented: “Ravi has made a significant contribution to the organization during his time with us. His drive and enthusiasm for advancing the recognition of the role of the Society itself and of pharmacists and professional practice is probably best reflected by his desire to ensure a real focus on personalized medicines and his work on equality and diversity, workforce wellbeing, and most recently the development of a new vision for pharmacy in England.

"He has developed stronger relationships and collaborative working with Government, Department of Health and Social Care, NHS England, professional leadership bodies, organisations and patient groups over the years to support implementation of our policies and advocacy work.

“Ravi became a Fellow of the Society in 2022, in well-deserved recognition of his contribution to the profession and I know we can expect to see him remain close to the work of the RPS and a real advocate for the Society’s professional leadership role.

Ravi Sharma commented: "It’s been an honour and a privilege to lead the team in England at RPS on behalf of our members, and the wider profession.

“I want to pay tribute to the dedication of my colleagues who have been instrumental in supporting the profession through Covid-19, raising the profile of pharmacy with NHS leaders and politicians and bringing our strategy on inclusion and diversity to life.

“Our recent collaborative work on co-creating a vision for pharmacy in England will provide the profession with a blueprint for the future. This work will continue, I look forward to seeing it develop from my new vantage point within the NHS.

“Improving care for patients and the public through pharmacy remains my personal mission. I am hugely excited about the opportunity to work with the senior leadership team at Bedfordshire Hospitals NHS Foundation Trust. I am looking forward to putting theory into practice, working with the fantastic team who are delivering critical NHS hospital services.

“I’m very appreciative of the fantastic opportunities I’ve had at RPS and I am confident the organisation will continue to represent the best of pharmacy and professional leadership in the future.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less